|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Recent progress on lanthanide complexes/clay minerals hybrid luminescent materials显示文摘The unique luminescent performance of lanthanide complexes/clay minerals hybrid materials has been fascinating many researchers for recent decades.It not only retains the excellent luminescent characteristics of lanthanide complexes but also improves the poor stability of the complexes.In this article,we introduce the luminescence mechanism of lanthanide complexes and point out the necessity of their combination with clay minerals.After the analysis of the structure and interlayer environment differences of 1:1-type and 2:1-type clay minerals,the intercalation methods(covalent grafting and ion exchange)appropriate for different clay minerals are summarized with examples.Based on the luminescence characteristics of the hybrid materials,the applications of these materials as luminescent probes in recognition of specific metal cations and molecules,detection of pH value,and temperature are reviewed.Finally,the current problems in the preparation of lanthanide complexes/clay minerals hybrid luminescent materials and shortcomings that need improvement in their performance are analyzed,and the application prospect is forecast. | Ga Zhang Lefu Mei Junjie Ding Ke Su Qingfeng Guo Guocheng Lv Libing Liao | 2022 | Journal of Rare Earths2022，40，9： | 2 |
| 2 | Ictal source analysis: localization and imaging of causal interactions in humans显示文摘 | Ding Lei Worrell GA Lagerlund TD | 2007 | Neuroimage2007，34，2： | 1 |
| 3 | Molecular and functional analysis of the human prothrombinase gene(HFGL2) and its role in viral hepatitis显示文摘 | Levy GA Liu M Ding J | 2000 | Am J Patho2000，156，4： | 1 |
| 4 | Telopeptides of type Ⅱ collagen upregulate proteinases an damage cartilage but are less effective than highly active fibronectin fragments显示文摘 | Guo D Ding L Homandberg GA | 2009 | Inflamm Res2009，58，3： | 1 |
| 5 | Molecular and functional analysis of the human prothrombinase gene(HFGL2)and its role in viral hepatitis显示文摘 | Levy GA Liu M Ding J | 2000 | Am J Pathol2000，156，： | 1 |
| 6 | Actuator fault robust estimation and fault tolerant control for a class of nonlinear descriptor systems 显示文摘 | Ga Z W Ding S X | 2007 | Automatica2007，43，5： | 1 |
| 7 | Cytotoxic ent-kaurane diterpenoids from Isodon racemosa(Hmesl)Hara显示文摘 | Ding L Liu GA Wang L | 2006 | Indian J Chem B2006，45，2： | 1 |
| 8 | Circumcision status and HIV infection among Black and Latino men who have sex with men in 3 US cities 显示文摘 | Millett GA Ding H Lauby J | 2007 | J Acquir Immune Defic Syndr2007，46，5： | 1 |
| 9 | Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis显示文摘 | Levy GA Liu M Ding J | 2000 | Am J Pathol2000，156，4： | 1 |
| 10 | Molecular and functional analysis of the human prothrombinase gene(HFGL2) and its role in viral hepatitis显示文摘 | Levy GA Liu MF Ding JW | 2000 | Am J Pathol2000，156，4： | 1 |
| 11 | Molecular and functional analysis of the human prothrombinase gene(hfgl 2) and its role in viral hepatitis显示文摘 | Levy GA Liu MF Ding JW | 2000 | Am J Pathol2000，156，4： | 1 |
| 12 | Molecular and functional analysis of the human prothrombinases gene(hFgl2) and its role in viral hepatitis显示文摘 | Levy GA Liu MF Ding JW | 2000 | Am J Pathol2000，156，4： | 1 |
| 13 | Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis显示文摘 | LEVY GA LIU MF DING JW | 2000 | Am J Pathol2000，156，4： | 1 |
| 14 | Molecular basis for PKR activation by PACT or dsRNA显示文摘 | Li S Peters GA Ding K | 2006 | Proc Natl Acad Sci USA2006，103，10： | 1 |
| 15 | The cartilage chondrolytic mechanism of fibronectin fragments involves MAP kinases:comparison of three fragments and native fibronectin显示文摘 | Ding L Guo D Homandberg GA | | 0，，10： | 1 |
| 16 | Telopeptides of type Ⅱ colla- gen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments 显示文摘 | Guo D Ding L Homandberg GA | 2009 | Inflamm Res2009，58，： | 1 |
| 17 | Telopeptides of type 11 collagen upregulate proteinases an damage cartilage but are less effective than highly active fibronectin fragments显示文摘 | Guo D Ding L Homandberg GA | | 0，，： | 1 |
| 18 | A single blunt impact on carti- lage promotes fibronectin fragmentation and upregulates cartilage de- grading stromelysin-1/matrix metalloproteinase-3 in a bovine ex vivo model显示文摘 | Ding L Guo D Homandberg GA | 2014 | Journal of Orthopaedic Research2014，32，6： | 1 |
| 19 | A single blunt impact on cartilage promotes fibronectin fragmentation and upregulates cartilage degrading stromelysin-1/matrix metalloproteinase-3in a bovine ex Vivo model显示文摘 | Ding L Guo D Homandberg GA | 2014 | J Orthop Res2014，32，6： | 1 |
| 20 | Pegylated Liposomal Doxorubicin as a Single Agent or as Combination Therapy with Carboplatin in Patients with Recurrent or Refractory Epithelial Ovarian Cancer显示文摘OBJECTIVE Pegylated liposomal doxorubicin (PLD;CAELYX^(?)), a novel formulation of doxorubicin with enhancedtherapeutic efficacy and reduced toxicity, has demonstratedimproved progression-free survival in recurrent or refractoryovarian cancer. The objective of this open-label, noncomparative,observational study was to determine the efficacyand safety of PLD monotherapy or combination therapy withcarboplatin for patients with recurrent or refractory ovariancancer.METHODS Sixty-two patients with recurrent or refractoryovarian cancer who completed a platinum-based chemotherapyregimen and demonstrated platinum sensitivity for first-linetreatment at least 6 months prior to study entry were enrolledin 20 centers in China. PLD was given as monotherapy (50mg/m^2 infused over 60 minutes) or as combination therapy(30 mg/m^2 1-hour infusion) with carboplatin (area under thecurve 5 mg.min/mL 1-hour infusion) on day 1 every 28 daysfor 4 cycles. The primary endpoint was objective response (OR)rate or CA-125 level. Secondary endpoints included time toresponse, time-to-progression, health-related quality of life, andsafety.RESULTS Overall, 48% of the 62 evaluable patients achieveda confirmed OR. More patients receiving PLD and carboplatinachieved an OR vs the PLD monotherapy group (63% vs. 37%).The median time to response and disease progression was58.5 days and 56.0 days, respectively. Overall and drug-relatedadverse events were reported for 39% and 34%, respectively.The most commonly reported adverse events were stomatitis(22.6%) and palmar-plantar erythroderma (9.7%). Two deathswere reported.CONCLUSION PLD is an effective and well tolerated agentin women with recurrent or refractory epithelial ovarian cancer. | Beihua Kong Yunong Gao Lingying Wu Ziting Li Yile Chen Mengda Li Yongliang Gao Ding ga Zhilan Peng KengShen | 2009 | Clinical oncology and cancer resexreh2009，6，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员